Huangqi injection (a traditional chinese patent medicine) for chronic heart failure: A systematic review

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Fu, Shufei ^a   Zhang, Junhua ^a   Menniti Ippolito, Francesca ^b   Gao, Xiumei ^a   Galeotti, Francesca ^b   Massari, Marco ^b   Hu, Limin ^a   Zhang, Boli ^b   Ferrelli, Rita ^b   Fauci, Alice ^b   Firenzuoli, Fabio ^c   Shang, Hongcai ^a   Guerra, Ranieri ^b   Raschetti, Roberto ^b  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c SAN GIUSEPPE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; HUANGQI; UNCLASSIFIED DRUG; HERBACEOUS AGENT; HUANG QI;

ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CHINA; CHINESE; CHINESE MEDICINE; COCHRANE LIBRARY; COUGHING; DIGITALIS INTOXICATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRY COUGH; EMBASE; FACIAL FLUSHING; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HOT FLUSH; HUMAN; MEDLINE; META ANALYSIS (TOPIC); NAUSEA; PATENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ASTRAGALUS PLANT; CHRONIC DISEASE; CLASSIFICATION; CLINICAL TRIAL (TOPIC); DRUG EFFECT; HEART STROKE VOLUME; INJECTION; META ANALYSIS; PATHOPHYSIOLOGY; REVIEW;

ASTRAGALUS PLANT; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; DRUGS, CHINESE HERBAL; HEART FAILURE; HUMANS; INJECTIONS; MEDICINE, CHINESE TRADITIONAL; PATENTS AS TOPIC; STROKE VOLUME; TREATMENT OUTCOME;

EID: 79955831169     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019604     Document Type: Article

References (89)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 112 (12): e154-235.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, et al. (2008) Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (4): e25-146.
3. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, et al. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). Eur Heart J 26: 1115-1140.
4. Gu D, Huang G, He J, Wu X, Duan X, et al. (2003) Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Chin J Cardiol 31 (1): 3-6.
5. Ramani GV, Uber PA, Mehra MR, (2010) Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc 85 (2): 180-95.
6. Guo R, Pittler MH, Ernst E, (2008) Hawthorn extract for treating heart failure. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD005312 DOI:10.1002/14651858.Cd005312.pub2.
7. Kroon PA, Iyer A, Chunduri P, Chan V, Brown L, (2010) The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem 17 (23): 2442-55.
8. Wongcharoen W, Phrommintikul A, (2009) The protective role of curcumin in cardiovascular diseases. Int J Cardiol 133 (2): 145-51.
9. Durst R, Lotan C, (2011) The potential for clinical use of cannabinoids in treatment of cardiovascular diseases. Cardiovasc Ther 29 (1): 17-22.
10. Fu S, Zhang J, Gao X, Xia Y, Ferrelli R, et al. (2010) Clinical practice of traditional Chinese medicines for chronic heart failure. Heart Asia 2: 24-27.Clinical practice of traditional Chinese medicines for chronic heart failure. Heart Asia 2: 24-27.
11. Zhenbao Island Pharmaceutical Co., Ltd. in Heilongjiang Province. (2007) Huangqi Injection. Chinese science and technology achievements database.
12. Fu T, Ji Y, He M, (2006) Industrialized research and development of Huangqi Injection. Chinese science and technology achievements database.
13. Jining Medical College Hospital. (2007) The clinical research on the effects of Huangqi Injection for blood plasma apoptosis correlation factor of chronic heart failure patients. Chinese science and technology achievements database.
14. Li M, Wang W, Xue J, Gu Y, Lin S, (2010) Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J EthnopharmacolOct 13, doi:10.1016/j.jep.2010.10.012.
15. Denzler KL, Waters R, Jacobs BL, Rochon Y, Langland JO, (2010) Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals. PLoS ONE 5 (9): e12561 doi:10.1371/journal.pone.0012561.
16. Cho WC, Leung KN, (2007) In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 252 (1): 43-54.
17. Ma A, Liu Z, Zhu W, Lv Z, Hua W, et al. (2007) Guidelines for the diagnosis and treatment of chronic heart failure in 2007. Chin J Cardiol 35 (12): 1076-1095.
18. Higgins JPT, Green S, eds. (2009) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration.
19. The Nordic Cochrane Centre, The Cochrane Collaboration (2008) Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen. Available: http://www.cc-ims.net/revman. Accessed 2011 Apr. 14.
20. StataCorp (2003) Stata Statistical Software: release 9.2. College Station, TX Stata Corporation.
21. Bai R, Li Q, Fang X, (1999) Therapeutic effect observation of Astragalus injection for the treatment of 25 cases of pulmonary heart failure. Journal of Shanxi Medical College of Continuing Education 9 (1): 39-40.
22. Bao X, (1999) Astragalus injection for aged people with congestive heart failure. Pharmacology and Clinics of Chinese Materia Medica 15 (6): 39-40.
23. Bu Q, Li S, (2005) The curative effect of Astragalus injection for aged patients with congestive heart failure. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease 3 (11): 1006.
24. Cai Q, Ma H, Zhou J, (2005) Analysis the improvement of cardiac function of Astragalus injection for chronic congestive heart failure. Shanxi Medical Journal 34 (7): 860-861.
25. Chu G, Peng X, (2000) Astragalus injection as assisted treatment for refractory heart failure. Hubei Journal of Traditional Chinese Medicine 22 (10): 29.
26. Fan L, (2004) Observation of Chinese and Western medicine for the treatment of 72 cases with congestive heart failure. Journal of Practical Traditional Chinese Medicine 20 (9): 501.
27. Fang Z, Qin Y, (2003) Clinical observation of Huangqi injection for congestive heart failure. Central Plains Medical Journal 30 (14): 6-7.
28. Fu X, (2000) Clinical experience in Astragalus injection for congestive heart failure. Journal of Chinese Practical Medicine 2 (9): 72.
29. Gao Z, Zhang L, Xu Y, Liu L, Zhang L, (1999) Clinical observation of Astragalus injection for congestive heart failure. Hebei Medicine 5 (5): 7-9.
30. Gao J, (2005) Clinical observation of Huangqi Injection for congestive heart failure. Journal of Guangdong College of Pharmacy 21 (5): 610-611.
31. Gu X, Shang S, Guo R, (2003) Astragalus injection as adjuvant therapy for 68 cases with congestive heart failure. Herald of Medicine 22 (8): 556-557.
32. Guo H, Liu L, Yuan W, Miao Z, (2005) Therapeutic effect observation of Huangqi injection for the treatment of chronic pulmonary heart disease with heart failure. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine 5 (4): 22.
33. Guo H, Chen H, (2006) Astragalus injection for 42 cases with chronic congestive heart failure. Central Plain Medical Journal 33 (2): 85-86.
34. Hu J, Gan J, (2001) Astragalus injection for 30 cases with chronic heart failure. Chin J Clin Pharmacol Ther 6 (1): 78.
35. Hu S, (2008) Therapeutic effect observation of Huangqi injection as assisted treatment for chronic heart failure. Medicine Innovation Research 5 (2): 102-103.
36. Jiao X, Duan Y, (2006) Clinical research of Huangqi Injection on left ventricular remodeling in congestive heart failure. Journal of Shanxi College of Traditional Chinese Medicine 29 (3): 19-20.
37. Li S, Lv M, (1997) Astragalus injection as the assisted treatment for 30 cases with pulmonary heart failure. Journal of Anhui TCM College 16 (2): 19-20.
38. Li C, Zhu X, (2002) Therapeutic effect observation of Astragalus injection as assisted treatment for chronic congestive heart failure. J Med Theor & Prac 15 (11): 1277-1278.
39. Li W, Zhao W, (2002) Clinical observation of Astragalus injection for 50 cases with chronic congestive heart failure. The Seventh National Chinese and Western Medicine Academic and Working Communication Conference of Rural Foot Layer 35-37.
40. Li S, Hao J, Wu F, et al. (2003) Clinical therapeutic effect observation of different doses of Huangqi injection for congestive heart failure. Chinese Journal of the Practical Chinese with Modem Medicine 3 (16): 1665-1667.
41. Li H, Xu J, (2006) The curative effect of the treatment of chronic congestive cardiac deficiency by Astragalue injection and digoxin. Sichuan Journal of Physiological Sciences 28 (2): 81.
42. Li J, Xu B, Xue J, Chen L, Ling W, (2007) Clinical observation on the effect of sodium nitroprusside combined with milkvetch root injection on chronic congestive heart failure. China Tropical Medicine 7 (8): 1343-1344.
43. Liu Y, Wang H, (2001) Curative effect observation of traditional Chinese and western medicine for the treatment of congestive heart failure. Tianjin Journal of Traditional Chinese Medicine 18 (5): 8.
44. Liu C, Li Y, (2004) Clinical observation of Huangqi injection for congestive heart failure. Journal of Liaoning College of TCM 6 (5): 390.
45. Liu Y, Li Y, (2005) Clinical research on Huangqi injection for congestive heart failure. Journal of Practical Traditional Chinese Medicine 21 (4): 198-199.
46. Liu Y, (2005) Effect of astragalus injection on heart failure in senile patients. Journal of Xinxiang Medical College 22 (3): 244-245.
47. Liu A, (2005) Clinical observation of Huangqi injection for chronic congestive heart failure. Zhejiang JLTCWM 15 (1): 32.
48. Liu Z, (2006) Effect of Huangqi injection on cardiac output of chronic heart failure. Journal of Chinese Modern Medicine 3: 5.
49. Lu Q, (2000) The treatment of 80 cases of intractable heart failure with traditional Chinese and Western medicine. Modern Journal of Integrated Traditional Chinese and Western Medicine 9 (1): 61.
50. Lu Z, Zhao D, Liu Y, (2006) Clinical observation of Astragalus injection for coronary heart failure. Public Medical Forum Magazine 10 (1): 1-2.
51. Luo X, (2003) Clinical observation of Astragalus injection for 30 cases with congestive heart failure. Journal of Emergency in Traditional Chinese Medicine 12 (1): 35.
52. Luo Q, Wang Y, Hu M, (2004) Therapeutic effect observation of Astragalus injection with conventional therapy for 46 elderly patients with chronic congestive heart failure. Heilongjiang Journal of Traditional Chinese Medicine 3: 8-9.
53. Lv J, (2008) Observation of western medicine combined with Huangqi injection for 36 patients with chronic heart failure. Journal of Practical Traditional Chinese Medicine 24 (3): 164-165.
54. Ma Z, Cheng X, Wang L, (2001) Huangqi injection as the assisted treatment for 86 cases with chronic pulmonary heart failure. Shanxi Journal of Traditional Chinese Medicine 22 (10): 579-580.
55. Ma L, Yu J, Han Y, (2005) Clinical observation of Huangqi injection for the treatment of pulmonary heart disease refractory heart failure. Henan Traditional Chinese Medicine 25 (10): 78.
56. Pang M, Guo F, Sun X, Guo L, (2000) Effective observation of Astragalus injection for refractory heart failure. China Pharmaceuticals 9 (7): 44.
57. Qin L, (2000) Therapeutic effect observation of Chinese and western medicine in the treatment of congestive heart failure. Journal of Shaanxi College of Traditional Chinese Medicine 23 (4): 46-47.
58. Su X, Liu C, (2002) Clinical observation of injection Huangqi treating 46 patients with heart failure. Journal of Heze Medical College 14 (3): 21.
59. Tian L, Ai J, Deng C, (1997) Clinical observation of Huangqi injection combined with captopril for the treatment of 46 cases with chronic pulmonary heart failure. Shanghai Medical & Pharmaceutical Journal 11: 16.
60. Tian L, Ai J, Wu X, (2005) Huangqi injection combined with dobutamine for the treatment of 54 patients with chronic pulmonary heart disease refractory heart failure. Modern Journal of Integrated Traditional Chinese and Western Medicine 14 (5): 610.
61. Wang L, (2000) The observation of Astragalus injection combined with Nitroglycerin for heart failure. Chongqing Medical Journal 29 (1): 71-72.
62. Wang S, Yu L, (2002) Clinical observation of astragalus in treatment of heart failure in 102 cases with chronic pulmonary heart disease. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 9 (4): 230-231.
63. Wang X, (2003) Combined metoprolol and Huangqi injection to treating 35 cases of heart failure from ischemic heart disease. Hunan Guiding Journal of TCM 9 (5): 15-17.
64. Wang H, (2005) Clinical research on Astragalus injection as assisted treatment for refractory heart failure. Journal of Emergency in Traditional Chinese Medicine 14 (11): 1070-1071.
65. Wei Y, Li C, Chen X, Liu Y, Luo N, (2006) Effect of Astragalus parenteral solution of cytokines and angiotensin II in patients with congestive heart failure. Chinese Journal of Clinical Rehabilitation 10 (3): 54-56.
66. Wu C, (2001) Clinical effects of Huangqi injection on heart failure. Guilin Medicine 3: 19-20.
67. Wu L, (2004) Therapeutic effect observation of Huangqi injection for the treatment of chronic pulmonary heart failure. Xinjiang Medical Journal 34: 107-108.
68. Xi Z, Jin X, (2005) Therapeutic effect observation of Astragalus injection for congestive heart failure. Modern Medicine & Health 21 (17): 2337-2338.
69. Yang L, Zhang Y, Yang G et al, (1996) The therapeutic effect of Astragalus injection on chronic heart failure. Shanghai Medical & Pharmaceutical Journal 2: 17-18.
70. Yang Z, Liu M, (1998) Effect of Huangqi injection on incidence of digitalism during the treatment of congestive heart failure. Traditional Chinese Drug Research & Clinical Pharmacology 9 (2): 80-81.
71. Yang J, Xie Q, (2000) Therapeutic effect observation of Huangqi injection for chronic heart failure. Modern Journal of Integrated Traditional Chinese and Western Medicine 9 (12): 1131.
72. Yang H, Kang X, (2005) Effects of Astragalus membranaceus on plasma BNP and NT-BNP during chronic heart failure. Chinese Health Care 13 (18): 9-10.
73. Yang Y, (2007) Therapeutic effect observation of Astragalus injection combined with Western medicine for congestive heart failure. World Health Digest 4 (11): 31-32.
74. Yin J, Wei Q, (2002) Therapeutic effect of Astragalus membranaceus injection on heart failure caused by pulmonary heart disease. Hebei Journal TCM 24 (4): 308-309.
75. Zeng J, (2005) The clinical observation of Astragalus injection for congestive heart failure. Academic Proceedings of National Emergency Medicine Conference on Serious Disease 156-157.
76. Zhai L, Wang M, Yue J, Ma Y, (1995) Clinical observation of Huangqi Injection for congestive heart failure. Shanghai Medical & Pharmaceutical Journal 11: 11-12.
77. Zhang L, Wang G, Zhang G, (2000) Therapeutic effect observation of Huangqi injection as assisted treatment for pulmonary heart failure. Tibetan Medical Journal 21 (2): 14-15.
78. Zhang D, (2002) Therapeutic effect observation of Astragalus injection for the treatment of 42 cases of pulmonary heart failure. Modern Journal of Integrated Traditional Chinese and Western Medicine 11 (5): 408.
79. Zhang J, Jia L, Du Y, (2003) Effects of Astragalus on cardiac function and hemorrheology in aged patients with congestive heart failure. Practical Geriatrics 17 (4): 192-194.
80. Zhang J, He H, Meng H, Wei G, Yang N, et al. (2005) Effect of Astragalus Injection on Plasma Levels of TNF-αIL-6 in Patients With Congestive Heart Failure. Chinese Archives of Traditional Chinese Medicine 23 (11): 2096-2098.
81. Zhao Z, Liu F, Yang L, (1998) Huangqi injection as the assisted treatment for congestive heart failure. The Practical Journal of Integrating Chinese with Modern Medicine 11 (1): 26.
82. Zhou Z, Cai A, Luo C, Zeng X, (2002) Clinical observation of Astragalus injection as adjuvant therapy for coronary heart failure. Hubei Journal of Traditional Chinese Medicine 24 (9): 11-12.
83. Ernst E, Lee MS, (2008) A trial design that generates only "positive" results. J Postgrad Med 54 (3): 214-6.
84. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit (1999) Note for guidance on clinical investigation of medicinal products for the treatment of cardiac failure. [Technical Report].
85. Xu L, Li J, Zhang M, Ai C, Wang L, (2008) Chinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journals. Contemp Clin Trials 29: 727-731.
86. Wu T, Li Y, Bian Z, Liu G, Moher D, (2009) Randomized trials published in some Chinese journals: how many are randomized? Trials 10: 46.
87. Jin Z, Yu D, Zhang L, Meng H, Lu J, et al. (2010) A Retrospective Survey of Research Design and Statistical Analyses in Selected Chinese Medical Journals in 1998 and 2008. PLoS ONE 5 (5): e10822.
88. Editorial, (2007) Reforming research in China. Lancet 369: 880.
89. Tang J-L, Liu B-Y, Ma K-W, (2008) Traditional Chinese medicine. Lancet 372: 1938-40.